Eginhard Schick

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

European bioanalysis forum recommendations for strengthening bioanalytical method transfer and validation through collaborative interactions.

European bioanalysis forum recommendations for strengthening bioanalytical method transfer and validation through collaborative interactions.

Journal: Bioanalysis

Published: May 24, 2026

Implementation of the fully automated diagnostic immunoanalyzer cobas e411 in the bioanalytical laboratory - Lessons learnt.

Implementation of the fully automated diagnostic immunoanalyzer cobas e411 in the bioanalytical laboratory - Lessons learnt.

Journal: Bioanalysis

Published: February 18, 2026

Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure.

Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure.

Journal: Frontiers in immunology

Published: March 24, 2024

Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies.

Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies.

Journal: Scientific reports

Published: November 29, 2022

Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab.

Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab.

Journal: Journal of pharmaceutical sciences

Published: August 20, 2021

Assay concept for detecting anti-drug IgM in human serum samples by using a novel recombinant human IgM positive control.

Assay concept for detecting anti-drug IgM in human serum samples by using a novel recombinant human IgM positive control.

Journal: Bioanalysis

Published: February 05, 2021

PKPD Assessment of the Anti-CD20 Antibody Obinutuzumab in Cynomolgus Monkey is Feasible Despite Marked Anti-Drug Antibody Response in This Species.

PKPD Assessment of the Anti-CD20 Antibody Obinutuzumab in Cynomolgus Monkey is Feasible Despite Marked Anti-Drug Antibody Response in This Species.

Journal: Journal of pharmaceutical sciences

Published: April 26, 2019

2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA/cell-based assays: immunogenicity, biomarkers and PK assays).

2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA/cell-based assays: immunogenicity, biomarkers and PK assays).

Journal: Bioanalysis

Published: November 30, 2018

Singlicate analysis in regulated bioanalysis using ligand-binding assays: where are we heading?

Singlicate analysis in regulated bioanalysis using ligand-binding assays: where are we heading?

Journal: Bioanalysis

Published: September 19, 2017

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

Journal: Toxicologic pathology

Published: August 24, 2017

Novel drug and soluble target tolerant antidrug antibody assay for therapeutic antibodies bearing the P329G mutation.

Novel drug and soluble target tolerant antidrug antibody assay for therapeutic antibodies bearing the P329G mutation.

Journal: Bioanalysis

Published: May 19, 2017

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity).

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity).

Journal: Bioanalysis

Published: November 19, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026